EIS 2024
Programme Outline
12:00 – 12:55
Registration & Networking - Light Lunch
13:00 – 13:10
Opening
Anat Loewenstein, President Euretina
Martin Zinkernagel, General Secretary Euretina
13:10 – 13:40
SESSION 1
Nonneovascular AMD and IRDs
Moderators: Kourous Rezaei / Frank Holz
13:10 Cedric Francois, Apellis
Committed to Saving Retina and Preserving Function in GA
13:15 Sharon Bakalash, Astellas
Revealing the Master Key: Unlocking Success in the Treatment of Geographic Atrophy
13:20 Tarek Hassan, Aviceda
Glycoimmunology in the Management of Geographic Atrophy from AMD
13:25 David Zacks, ONL Therapeutics
Targeting Fas Pathway: ONL Therapeutics’ Approach to Dry AMD
13:30 Panel Discussion
Kourous Rezaei, Frank Holz, Cedric Francois, Sharon Bakalash, Tarek Hassan & David Zacks
13:45 – 14:25
SESSION 2
VEGF related and other retinal indications
Moderators: Anat Loewenstein / Francesco Bandello
13:45 Sascha Fauser, Roche
Roche’s Commitment to Ophthalmology – Building an Innovative Pipeline
13:50 Julian Smith, Abbvie
A Commitment to Addressing Unmet Needs in Retinal Diseases
13:55 Jennifer Kissner, Outlook Therapeutics
Redefining the Standard of Care for Bevacizumab as an Anti VEGF for Retina
14:00 Ramiro Ribeiro, Eyepoint Pharmaceuticals
Committed to Developing Therapeutics to Help Improve the Lives of Patients with Serious Retinal Diseases
14:05 Nadia K Waheed, Ocular Therapeutix
Changing the Future Paradigm for the Management of Retinal Vascular Diseases
14:10 Star Seyedkazemi, Adverum Biotech
Ixo-vec: Addressing the Unmet Needs in wet AMD Treatment
14:15 Panel Discussion
Anat Loewenstein, Francesco Bandello, Sascha Fauser, Julian Smith, Jennifer Kissner, Ramiro Ribeiro & Nadia K. Waheed
14:30 – 15:00
SESSION 3
Nonneovascular AMD and IRDs
Moderators: Kourous Rezaei / Frank Holz
14:30 Remko Bakker, Boehringer Ingelheim
Driving Innovation Beyond Anti-VEGF
14:35 Sam Barone, Nanoscope Therapeutics
Breakthrough in Vision Restoration: Mutation-agnostic Optogenetics for Inherited Retinal Diseases and Geographic atrophies
14:40 Ralf Hornig, SCIENCE
The PRIMA Retinal Implant for Patients with Geographic Atrophy
14:45 Kirsten Vonde, Granzer Regulatory Consulting & Services
Development and Regulatory Thoughts for Gene Therapies in AMD
14:50 Panel Discussion
Kourous Rezaei, Frank Holz, Remko Bakker, Sam Barone, Ralf Hornig & Kirsten Vonde
15:05 – 15:30
SESSION 4
Investor Panel
Moderators: Anat Loewenstein / Kourous Rezaei
Round Table Discussion: Anta Gkelou/SOFINNOVA PARTNERS, Edward Van Wezel/ BIOGENERATION VENTURES, Bonnie van Wilgenburg/MONOGRAPH BIO
15:30 – 16:00
NETWORKING BREAK
16:00 – 16:35
SESSION 5
VEGF related and other retinal indications
Moderators: Anat Loewenstein / Francesco Bandello
16:00 Sergio Leal, Bayer
Bayer’s Vision for the Future of Ophthalmology
16:05 Riad Sherif, Oculis
OCS-01, an OPTIREACH® Formulation of High Concentration Dexamethasone Eye Drop, for the Treatment of DME
16:10 Frederic Guerard, Opthea
Sozinibercept in Wet AMD: Potential for Superior Vision Outcomes Beyond Anti-VEGF-A Therapies
16:15 Robert Kim, 4D Molecular Therapeutics
4D Molecular Therapeutics: New Era of Genetic Medicine
16:20 Sumie Takahara, Regenxbio
Innovation to Address Unmet Needs in Retinal Diseases
16:25 Panel Discussion
Anat Loewenstein, Francesco Bandello, Sergio Leal, Riad Sherif, Frederic Guerard, Robert Kim & Sumie Takahara
16:40 – 17:25
SESSION 6
Innovations in Retinal Surgery, Imaging, and AI
Moderators: Alistair Laidlaw / Tunde Peto
16:40 Stephanie Magazzeni, Zeiss
Workflows, Imaging & AI: ZEISS Game Changers from the Office to the OR
16:45 Derek Swan, Optos
Recent Advances in Multimodal Ultrawidefield Retinal Imaging
16:50 Dimitris Aktypis, Alcon
Alcon – Innovation Lights the Path to Sight
16:55 Pierre Billardon, DORC
Clinically Relevant Innovation in Retina Surgery
17:00 Helge Menz, Pharmpur
Let There be Light – Challenges and Solutions
17:05 Carlos Ciller, Retinai
Transforming Healthcare: Unlocking the Power of Data to Improve R&D and Patient Outcomes
17:10 Panel Discussion
Alistair Laidlaw, Tunde Peto, Stephanie Magazzeni, Derek Swan, Dimitris Aktypis, Pierre Billardon, Helege Menz, Carlos Ciller, Grazia Pertile & Stela Vujosevic
17:30 – 17:51
SESSION 7
Rapid Fire Panel Discussion
Moderators: Martin Zinkernagel / Arshad Khanani
17:30 Stephanie Campbell, Okko Health
Proactive Disease Management Using Smartphone Self-Monitoring
17:33 Kester Nahen, Notal Vision
SCANLY Home OCT Monitoring Program – A New Patient Management Paradigm
17:36 Ioanna Psalti, EU EYE
EUEYE: from Bench to Bedside to Policy Innovation and Back
17:39 Amir Sadeghipour, Retinsight
Revealing the Invisible: An automated GA Monitor Enhances Diagnostic Efficacy
17:42 Manuel Opitz, deepeye Medical GmbH
From “treat & extend” to “predict & treat”: The AI Co-pilot for Anti-VEGF Treatment in Busy Clinics to Drive Outcomes & Adherence
17:45 Christian Roesky, Novaliq
Novaliq’s Water-Free Eye Drops: A New Treatment Paradigm for Diabetic Retinopathy
17:48 Brad Doerschuk, InFocus Clinical Research
Enhancing Clinical Trials with Real-Time Intelligence (RTI): A Revolutionary Approach
17:51 – 17:56
Closing Remarks
Nicole Eter
17:56
Networking - Drinks & light canapes
Please note, this programme may be subject to change.
